A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL
Condition: Follicular Lymphoma Interventions: Drug: Obinutuzumab; Drug: Lenalidomide; Drug: Bendamustine; Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Vincristine; Drug: Prednisone Sponsor: Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials